ALKS

ALKERMES PLC

Healthcare | Mid Cap

$0.40

EPS Forecast

$369

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2025-12-31
BMRNBiomarin Pharmaceutical IncALNYAlnylam Pharmaceuticals IncIONSIonis Pharmaceuticals IncRAREUltragenyx Pharmaceutical IncSRPTSarepta Therapeutics IncJAZZJazz Pharmaceuticals PlcNKTRNektar TherapeuticsPAHCPhibro Animal Health Corp